MoneyWorks4Me

The company witnessed a 10.22% growth in the revenue at Rs. 1913.60 millions for the quarter ended March 2026 as compared to Rs. 1736.10 millions during the year-ago period.A good growth in profit of 26.59% reported to Rs. 1095.00  millions over Rs. 865.00 millions of corresponding previous quarter.The company reported a good operating profit of 1446.70 millions compared to 1162.90 millions of corresponding previous quarter.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202603 202503 % Var 202603 202503 % Var 202603 202503 % Var
Sales 1913.60 1736.10 10.22 7383.30 7524.10 -1.87 7383.30 7524.10 -1.87
Other Income 610.80 412.50 48.07 1953.70 1345.90 45.16 1953.70 1345.90 45.16
PBIDT 1446.70 1162.90 24.40 5331.50 4665.60 14.27 5331.50 4665.60 14.27
Interest 0.50 0.40 25.00 2.00 1.20 66.67 2.00 1.20 66.67
PBDT 1446.20 1162.50 24.40 5329.50 4664.40 14.26 5329.50 4664.40 14.26
Depreciation 69.00 60.90 13.30 254.30 247.70 2.66 254.30 247.70 2.66
PBT 1377.20 1101.60 25.02 5075.20 4416.70 14.91 5075.20 4416.70 14.91
TAX 282.20 236.60 19.27 1109.40 1021.80 8.57 1109.40 1021.80 8.57
Deferred Tax 17.70 0.30 5800.00 14.50 -7.20 -301.39 14.50 -7.20 -301.39
PAT 1095.00 865.00 26.59 3965.80 3394.90 16.82 3965.80 3394.90 16.82
Equity 152.00 152.00 0.00 152.00 152.00 0.00 152.00 152.00 0.00
PBIDTM(%) 75.60 66.98 12.87 72.21 62.01 16.45 72.21 62.01 16.45
Peers
Company Name CMP
Sun Pharma. Inds. 1853.00
Dr. Reddys Labs. 1200.40
Cipla 1404.00
Lupin 2098.00
Zydus Lifesciences 1180.00
View more..